Chief Executive Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Francois Cedric, sells 5,000 shares worth $196,900
According to Apellis Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 17 07:13 PM, company Chief Executive Officer, Francois Cedric disclosed selling 5,000 shares at a cost of $39.38. At the time of this transaction (Nov 16), this trade was worth $196,900 in total. As of Nov 16, Francois Cedric now owns 1,078,079 shares in total worth about $44,470,758.75.
For the last few recent trades made by Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Chief Executive Officer, Francois Cedric, we have the following information:
- SEC Form 4 filing: Aug 20: Sold 3,457 shares at the rate of $30.00 per share. Total worth of this trade was $103,710. Total number of shares owned as of Aug 20 were 1,093,079
- SEC Form 4 filing: Aug 18: Sold 1,543 shares at the rate of $30.00 per share. Total worth of this trade was $46,290. Total number of shares owned as of Aug 18 were 1,096,536
Posted by
George Daniels
on Tuesday November 17 2020, 10:35 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
